NCT00239486View on ClinicalTrials.gov

Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)

PHASE2CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Restless Legs Syndrome
Interventions
DRUG

Pramipexole

Trial Locations (1)

FIN-00250

NEURO, Helsinki

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00239486 - Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS) | Biotech Hunter | Biotech Hunter